| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RVMD | Common Stock | Options Exercise | $68.2K | +16.7K | +6.3% | $4.09 | 281K | Oct 14, 2024 | Direct | F1, F2 |
| transaction | RVMD | Common Stock | Sale | -$694K | -14.1K | -5% | $49.38 | 267K | Oct 14, 2024 | Direct | F1, F2, F3 |
| transaction | RVMD | Common Stock | Sale | -$131K | -2.61K | -0.98% | $50.08 | 264K | Oct 14, 2024 | Direct | F1, F2, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RVMD | Stock Option (Right to Buy) | Options Exercise | $0 | -16.7K | -41.67% | $0.00 | 23.3K | Oct 14, 2024 | Common Stock | 16.7K | $4.09 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024. |
| F2 | Includes 86,400 restricted stock units. |
| F3 | The transaction was executed in multiple trades in prices ranging from $48.95 to $49.94, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F4 | The transaction was executed in multiple trades in prices ranging from $49.95 to $50.27, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
President, Research and Development